Loading...
Farydak (Panobinostat): First HDAC Inhibitor Approved for Patients with Relapsed Multiple Myeloma
Saved in:
| Published in: | Am Health Drug Benefits |
|---|---|
| Main Author: | |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Engage Healthcare Communications, LLC
2016
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5013857/ https://ncbi.nlm.nih.gov/pubmed/27668050 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|